MARKET

BBI

BBI

Brickell Biotech Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.626
+0.046
+2.92%
After Hours: 1.630 +0.004 +0.23% 17:09 01/17 EST
OPEN
1.580
PREV CLOSE
1.580
HIGH
1.736
LOW
1.540
VOLUME
243.66K
TURNOVER
--
52 WEEK HIGH
8.96
52 WEEK LOW
1.220
MARKET CAP
12.70M
P/E (TTM)
-0.8907
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BBI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BBI News

  • DDD, NVTA among premarket gainers
  • Seeking Alpha - Article.4d ago
  • Brickell Bios Development Partner, Kaken Pharmaceutical, Submits New Drug Application for Sofpironium Bromide in Japan for Primary Axillary Hyperhidrosis
  • GlobeNewswire.01/10 21:05
  • Key events next week - healthcare
  • Seeking Alpha - Article.12/20/2019 20:22
  • The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic
  • Benzinga.12/19/2019 12:52

More

Industry

Biotechnology & Medical Research
-0.10%
Pharmaceuticals & Medical Research
+0.07%

Hot Stocks

Name
Price
%Change

About BBI

Brickell Biotech, Inc., formerly Vical Incorporated, is a clinical-stage pharmaceutical company that focuses on the development of therapeutics for the treatment of skin diseases. The Company’s pipeline consists of molecular entities targeting the treatment of the indications, such as hyperhidrosis, cutaneous T-cell lymphoma, allergic contact dermatitis, psoriasis and androgenic alopecia. The Company’s product candidates include BBI-3000, BBI-6000 and Sofpironium Bromide. Sofpironium Bromide is a topical soft anticholinergic for axillary hyperhidrosis. BBI-3000 is an oral rexinoid for cutaneous T-cell lymphoma. BBI-6000 is a retinoic acid-related orphan nuclear receptor gamma antagonist, which is develops for psoriasis.
More

Webull offers Brickell Biotech Inc (BBI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.